Form 4: Klaviyo Director Tony Weisman Executes Stock Transactions
SEC Form 4 Filing
Director Tony Weisman of Klaviyo, Inc. reports the sale and acquisition of Series A Common Stock on February 29, 2024.
Summary
- Tony Weisman, a director at Klaviyo, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On February 29, 2024, Weisman acquired 33,333 shares of Series A Common Stock and disposed of 33,333 shares of Series A Common Stock at a price of $25.97.
- The shares were sold in multiple transactions at prices ranging from $25.91 to $26.10.
- Following these transactions, Weisman directly owns no shares of Series A Common Stock.
- Weisman also indirectly owns 75,000 shares of Series B Common Stock, including 8,333 unvested restricted stock units which vested on March 1, 2024.
- An additional 20,833 shares of Series B Common Stock are held in a trust for which Weisman serves as trustee.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the buying and selling activities of company directors.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders.
- The information disclosed is consistent with SEC regulations and reporting requirements.
- Comparable companies such as Braze and Salesforce also have insiders who file Form 4s when they trade company stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders, as they provide insight into insider trading activity.
- The vesting of RSUs impacts the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of stock transactions (acquisition and disposition of Series A Common Stock). |
| 03/01/2024 | Remaining 8,333 RSUs vested and settled as 8,333 shares of Series B Common Stock. |
| 03/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.